TY - JOUR
T1 - Status of wound management in Korea
AU - Namgoong, Sik
AU - Han, Seung Kyu
N1 - Funding Information:
The biotechnology industry (or the “bioindustry”) has high value-added, and is unique in that research from basic life sciences can be applied immediately in the applied sciences of medicine and pharmacology. Recognizing the highly qualified resources in both treatment and research, the South Korean government has long viewed the bioindustry as one with much potential to propel further economic growth and has supported investment in research and development in this field since the 1990s. A 2017 report published by the Health and Welfare Committee of the Republic of Korea National Assembly stated that since the 1st Framework Plan for Biotechnology Promotion invested USD 53.6 million in 1994 for biotechnology research, government funding has been increasing by an average of 20% each year, recording USD 2,338.8 million in 2015.
Publisher Copyright:
© 2017 by the Wound Healing Society
PY - 2018/12
Y1 - 2018/12
N2 - In spite of a period of intense economic, social, and political hardship following the Korean War, the Republic of Korea has made great strides in economic growth over the past half century, and also remarkable progress in the medical field. However, wound research has been slow to take off in South Korea. Meanwhile, as is the case in many countries in Western Europe and North America, South Korea is seeing a steady increase in its aged population. The growth in the geriatric population has in turn brought on more cases of chronic wounds. Though South Korea only began to recognize the importance of wound management in the early 2000s, it was fortunate enough to have sophisticated related industries, such as biotechnology and information technology, and brilliant, industrious, and eager wound researchers, contributing to rapid development of the field. The country has particular strengths in research for innovative cell-based treatments and products for managing wounds. Notwithstanding government policy ill-equipped to sufficiently support such advancement, better communication between experts and public officials will no doubt bring forth even more achievements in this very promising field. It is in this context that this article aims to summarize current wound management practices, research, training, product development, and government policies regarding wound management in South Korea as of the year 2017.
AB - In spite of a period of intense economic, social, and political hardship following the Korean War, the Republic of Korea has made great strides in economic growth over the past half century, and also remarkable progress in the medical field. However, wound research has been slow to take off in South Korea. Meanwhile, as is the case in many countries in Western Europe and North America, South Korea is seeing a steady increase in its aged population. The growth in the geriatric population has in turn brought on more cases of chronic wounds. Though South Korea only began to recognize the importance of wound management in the early 2000s, it was fortunate enough to have sophisticated related industries, such as biotechnology and information technology, and brilliant, industrious, and eager wound researchers, contributing to rapid development of the field. The country has particular strengths in research for innovative cell-based treatments and products for managing wounds. Notwithstanding government policy ill-equipped to sufficiently support such advancement, better communication between experts and public officials will no doubt bring forth even more achievements in this very promising field. It is in this context that this article aims to summarize current wound management practices, research, training, product development, and government policies regarding wound management in South Korea as of the year 2017.
UR - http://www.scopus.com/inward/record.url?scp=85056803867&partnerID=8YFLogxK
U2 - 10.1111/wrr.12576
DO - 10.1111/wrr.12576
M3 - Article
C2 - 28857399
AN - SCOPUS:85056803867
SN - 1067-1927
VL - 26
SP - S3-S8
JO - Wound Repair and Regeneration
JF - Wound Repair and Regeneration
ER -